Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 42708-141 by Qpharma Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Label - 42708 141 30

Label - 42708 141 30

This is a medication label for Atorvastatin Calcium tablets in 20mg strength. The dosage instructions are to be found in the package insert, and the tablets are to be stored at room temperature. The container should be kept tightly closed and out of reach of children. The label suggests taking the tablet 1-2 times a day, but the exact dosage is not specified. The medication is distributed by QPharma, Inc. and is only available through prescription (Rx only).*

atorvastatin-fig-1 - atorvastatin fig 1

atorvastatin-fig-1 - atorvastatin fig 1

This appears to be a graph showing the cumulative incidence of a medical condition or event over a period of 35 years. The two lines on the graph, labeled "Atorastatn" and "Placsbo," likely represent different treatments or groups being compared. The numbers on the y-axis indicate the percentage of people who have experienced the condition/event, while the numbers on the x-axis indicate the number of years that have passed. The HR value of 0.64 and p-value of 0.0005 suggest that there is a statistically significant difference between the two groups/treatments.*

atorvastatin-fig-2 - atorvastatin fig 2

atorvastatin-fig-2 - atorvastatin fig 2

This is a statistical data comparison between the effects of Placebo and Atorvastatin on Cumulative Hazard at a specific time frame of 4 years. Atorvastatin shows a decrease in hazard percentages compared to Placebo with a significant level of 0.001.*

atorvastatin-fig-3 - atorvastatin fig 3

atorvastatin-fig-3 - atorvastatin fig 3

This text presents the results of a study on the effects of Atorvastatin on major cardiovascular endpoints. The table shows the percentage of subjects who experienced the event, with 0.2 being the lowest percentage. Two different dosages of Atorvastatin were used, and the HR (hazard ratio) was calculated at 0.78 for the 80 mg dosage. The graph shows the time to the first major cardiovascular endpoint over a period of 4 years.*

atorvastatin-st - atorvastatin st

atorvastatin-st - atorvastatin st

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.